X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-29-2023-18805.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-21-2022-99399.pdf
https://www.prnewswire.com/news-releases/preparation-products-of-yiling-pharma-approved-by-fda-for-launch-in-the-us-market-301134272.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212041
https://health.economictimes.indiatimes.com/news/pharma/lupin-sun-pharma-recall-lisinopril-and-clonazepam-respectively-in-the-us-market/77445387
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-17-2020-1592377204.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-29-2020-1588138644.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-8-2020-1586323768.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-25-2020-1585131468.pdf
https://www.fiercepharma.com/pharma/astrazeneca-hawks-suite-hyptertension-drugs-for-350m-latest-asset-sale
https://endpts.com/after-a-brief-break-astrazeneca-is-back-at-divesting-handing-off-hypertension-meds-for-350m/
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/glenmark-recalls-products-from-us-market/articleshow/70826067.cms
https://www.biospace.com/article/newly-branded-azurity-wins-fda-approval-for-liquid-form-of-amlodipine/
https://www.forbes.com/sites/robertglatter/2018/10/27/common-blood-pressure-medication-linked-to-increased-risk-of-lung-cancer/#5cbb12807b4e
https://www.pharmacompass.com/pdf/news/Enforcement-Report-Week-of-August-22-2018-1534903909.pdf
https://www.biopharmadive.com/news/state-prescription-popularity-thyroid-opioid-drug/519870/
https://www.pharmacompass.com/pdf/news/top-selling-top-prescribed-drugs-for-2016-1507784462.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204058
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-22-2017-1487758756.pdf
http://www.prnewswire.com/news-releases/qbrelis-the-first-and-only-lisinopril-oral-solution-1-mgml-for-pediatric-patients-6-years-of-age-and-older-is-now-available-300351896.html
http://www.business-standard.com/article/companies/sun-will-recall-31-762-bottles-of-anti-depressant-116101200797_1.html
http://www.prnewswire.com/news-releases/fda-approves-qbrelis-the-first-and-only-lisinopril-oral-solution-1-mgml-for-pediatric-patients-6-years-of-age-and-older-300306412.html
http://portal.anvisa.gov.br/wps/content/anvisa+portal/anvisa/sala+de+imprensa/menu+-+noticias+anos/201616/anvisa+suspende+lote++do+medicamento+lisinopril
http://www.pharma-excipients.ch/2016/02/19/design-and-evaluation-of-buccal-patch-containing-combination-of-hydrochlorothiazide-and-lisinopril/
http://www.financialexpress.com/article/industry/companies/unimark-in-talks-to-sell-carbapenen-unit/183288/
http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-1346-2015&w=08262015&lang=eng
Market Place
Share 
